AM PM Group Limited (AMPM) has filed for 1,500,000 share IPO at $4-$5 per share.

Investing.com -- Corteva shares fell about 5.7% on Monday following a Wall Street Journal report that the U.S. agrichemicals company is considering separating its seed and crop protection chemical ...

Freshpet Inc (FRPT) stock reached a 52-week low, hitting a price of 52.26 USD. This marks a significant decline for the pet food company, which has seen its stock value decrease by 62.75% over the ...

Accenture stock reached a 52-week low, trading at $236.63, marking a significant point of concern for investors. According to InvestingPro data, the stock’s RSI indicates oversold territory, while the ...

On Monday, the Metropolitan Transportation Authority announced that the unions had postponed their planned work stoppage. Instead, union representatives revealed at a press conference that they have ...

The rally in uranium-related stocks comes as the U.S. government looks to strengthen its domestic uranium reserves, which are critical for nuclear power generation and national security purposes.

Investing.com -- Israeli Prime Minister Benjamin Netanyahu informed U.S. President Donald Trump about Israel’s plan to attack Hamas leaders in Qatar before the strike took place last week, according ...

Monday’s market has witnessed notable movements among stocks across the board, with significant activity in the mega-cap and large-cap sectors. Tesla Motors (TSLA) and Google Inc (GOOGL) have shown ...

Earnings season marches on, and we’re here to spotlight the companies gearing up to report their financial results for the upcoming trading day. Leading the pack are Ferguson, Kirklands, and Ispire ...

As traders approach another pivotal day for financial markets, Tuesday, September 16, 2025, brings a series of crucial ...

The comments follow a U.S. military strike in the Caribbean earlier this month that killed 11 people and sank a Venezuelan boat. The Trump administration claimed the vessel was transporting illegal ...

The biotech sector has been one of the market’s laggards for several years now, and 2025 has been no different, at least on the surface. Year-to-date, the iShares Nasdaq Biotechnology ETF, which ...